Is a complete LPCN research report available?

No complete published report is available for Lipocine Inc. (LPCN) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Lipocine Inc. (LPCN)

NASDAQ: LPCN · USD

$2.11

+0.04 (+1.9%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-31 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first LPCN analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	17.4M
Revenue (ttm)	2M
Net income (ttm)	-11.4M
EPS (ttm)	-$1.97
Shares out	8.2M
Volume	58,344
Beta	0.44
Price target	$6.00	+184.4%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 2M
Net income (ttm): -11.4M
EPS (ttm): -$1.97
Market cap: 17.4M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	27.4B	36.9x	5.7x	96.6%	+47.5%	-37.8%	Strong Buy
ARGX	argenx SE	53.8B	31.3x	10.1x	50.6%	+58.8%	+45.7%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All LPCN indicators

Market & fundamental data

Available fields

201

Groups with data

Currency

USD

Showing 201 of 201 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001535955
Company name	Lipocine Inc.
Country	United States
Country code	US
Cusip	53630X203
Employees	14
Employees Change	-2%
Employees Change Percent	-12.5
Enterprise value	$-7.2M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US53630X2036
Last refreshed	2026-07-31
Market cap	$17.4M
Market cap category	Nano-Cap
Price	$2.11
Price currency	USD
Rev Per Employee	143,015x
Sector	Healthcare
Sector PE	45.56
Sector PE Fwd	24.38
Sic	2834
Symbol	LPCN
Website	https://www.lipocine.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-65.06%
FCF yield	-57.17%
P/B ratio	0.68x
P/S ratio	8.78x
PS Forward	26.75x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-605.86%
EBITDA Margin	-602.87%
Gross margin	100%
Gross Profit	$2M
Gross Profit Growth	-45.52%
Gross Profit Growth Q	27.2%
Gross Profit Growth3 Y	53.37%
Net Income	$-11.4M
Net Income Growth Years	0%
Pretax Margin	-571.1%
Profit Per Employee	$-816,752
ROA	-33.07
Roa5y	-16.96
ROCE	-53.13
ROE	-54.41
Roe5y	-28.24
ROIC	-36.08

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-28.77%
Cagr1y	-35.49%
Cagr3y	-24.53%
Cagr5y	-37.77%
EPS Growth Years	0
Revenue Growth	-45.52x
Revenue Growth Q	27.2x
Revenue Growth Quarters	1x
Revenue Growth Years	0x
Revenue Growth3 Y	53.37x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.09
Assets	$25.4M
Cash	$24.7M
Current Assets	$25.2M
Current Liabilities	$2.5M
Debt	$0
Equity	$22.8M
Liabilities	$2.5M
Long Term Assets	$113,232
Long Term Liabilities	$0
Net Cash	$24.7M
Net Cash By Market Cap	$141
Net Cash Growth	25.41%
Net Debt Equity	$-1.08
Tangible Book Value	$22.8M
Tangible Book Value Per Share	$3.05
WACC	6.66

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	9.99
Net Working Capital	$-2M
Quick ratio	9.87
Working Capital	$22.7M
Working Capital Turnover	$0.1

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-8.67%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-96.64%
1Y total return	-35.47%
200-day SMA	4.59
3Y total return	-57.03%
50-day SMA	2.28
50-day SMA vs 200-day SMA	50under200
5Y total return	-90.67%
All Time High	340
All Time High Change	-99.38%
All Time High Date	2013-08-28
All Time Low	1.81
All Time Low Change	16.57%
All Time Low Date	2026-04-02
ATR	0.12
Beta	0.44
Beta1y	-0.43
Beta2y	0.36
Ch YTD	-73.72
High	2.2
High52	12.37
High52 Date	2026-01-15
High52ch	-82.94%
Low	2.05
Low52	1.81
Low52 Date	2026-04-02
Low52ch	16.58%
Ma50ch	-7.33%
Price vs 200-day SMA	-54.05%
RSI	39.68
RSI Monthly	40.95
RSI Weekly	35.34
Sharpe ratio	0.48x
Sortino ratio	0.64
Total Return	-8.67%
Tr YTD	-73.72
Tr1m	-15.26%
Tr1w	-3.65%
Tr3m	-7.86%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	2
Analyst Count Top	0
Analyst Ratings	Buy
Earnings EPS Estimate	$-0.41
Earnings Revenue Estimate	190,400x
Earnings Revenue Estimate Growth	-69.43x
Operating Income	$-12.1M
Operating margin	-605.9
Price target	$6
Price Target Change	$184

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	6,912,466%
Float Percent	83.85%
Shares Insiders	4.53%
Shares Institutions	26.31%
Shares Out	8,244,253
Shares Qo Q	19.61%
Shares Yo Y	8.67%
Short Float	1.78%
Short Ratio	1.89
Short Shares	1.49

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-10.3M
Adjusted OCF	-10,285,494
Average Volume	34,028.7x
Bv Per Share	3.05
Ch10y	-96.64
Ch1m	-15.26
Ch1w	-3.65
Ch1y	-35.47
Ch3m	-7.86
Ch3y	-57.03
Ch5y	-90.67
Ch6m	-76.53
Change	1.93%
Change From Open	2.93
Close	2.07
Days Gap	-0.97
Depreciation Amortization	60,026
Dollar Volume	123,105.8
Earnings Date	2026-08-07
Earnings Time	bmo
EBIT	$-12.1M
EBITDA	$-12.1M
EPS	$-1.97
F Score	1
FCF	$-10M
FCF EV Yield	140.48x
FCF Per Share	$-1.22
Financing CF	14,840,594
Fiscal Year End	December
Founded	1,997
Investing CF	-3,130,981
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Date	2023-05-12
Last Split Type	Reverse
Last10k Filing Date	2026-03-10
Ma150	5.09
Ma150ch	-58.56%
Ma20	2.27
Ma20ch	-7.21%
Net CF	1,661,012
Next Earnings Date	2026-08-11
Open	2.05
Optionable	No
Position In Range	40
Post Close	2.11
Postmarket Change Percent	0.94
Postmarket Price	$2.13
Ppne	89,479
Price Date	2026-07-30
Ptbv Ratio	0.77
Relative Volume	1.72x
Revenue	2,002,210x
SBC By Revenue	11.83x
Share Based Comp	236,893
Tr6m	-76.53%
Us State	Utah
Volume	58,344
Z Score	-6.07

Lipocine Inc. (LPCN)

Coverage state: Market snapshot only — no published research

Generate the first LPCN analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · LPCN

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All LPCN indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on LPCN

Frequently asked questions